Showing results (51-60 of 142) with videos related to
Sort By:
Pageof 15
Human Reproduction (Oxford, England)|July 10, 2008
Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiationMorten F Gjerstorff, Linda Harkness, Moustapha Kassem, et al.F1000Research|August 20, 2016
Robust de novo pathway enrichment with KeyPathwayMiner 5Nicolas Alcaraz, Markus List, Martin Dissing-Hansen, et al.Genes|March 6, 2021
HMGA2 as a Critical Regulator in Cancer DevelopmentBehzad Mansoori, Ali Mohammadi, Henrik J Ditzel, et al.Oncoimmunology|June 23, 2017
Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumorsMartin H Pedersen, Brian L Hood, Hans Christian Beck, et al.Breast Cancer Research and Treatment|February 2, 2012
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancerKarina H Gravgaard, Maria B Lyng, Anne-Vibeke Laenkholm, et al.The Journal of Experimental Medicine|September 30, 2018
KDM4B-regulated unfolded protein response as a therapeutic vulnerability in PTEN-deficient breast cancerWenyu Wang, Gokce Oguz, Puay Leng Lee, et al.Molecular & Cellular Proteomics : MCP|March 27, 2009
Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometryRikke Leth-Larsen, Rikke Lund, Helle V Hansen, et al.Cancers|December 23, 2022
PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast CancerMorten F Gjerstorff, Sofie Traynor, Odd L Gammelgaard, et al.The Journal of Biological Chemistry|March 30, 2002
Cancer-associated cleavage of cytokeratin 8/18 heterotypic complexes exposes a neoepitope in human adenocarcinomasHenrik J Ditzel, Merel C M Strik, Morten K Larsen, et al.Journal for Immunotherapy of Cancer|December 4, 2025
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trialOdd Lilleng Gammelgaard, Sidse Ehmsen, Anne Marie Bak Jylling, et al.Pageof 15